Abstract
The clinical formulation of the anti-tumour agent Taxol involves the use of a mixture of ethanol and Cremophor EL. Gel electrophoresis and density-gradient ultracentrifugation were used to detect effects of Taxol infusions on serum lipoproteins. Use of the Cremophor vehicle results in a decrease in the electrophoretic mobility of serum lipoproteins along with the appearance of a lipoprotein dissociation product. These effects persist during a 24 h infusion and for at least 1.5 h afterwards, and can be reproduced in vitro using purified high-density lipoprotein (HDL) or low-density lipoprotein (LDL). In control serum, Taxol binds to albumin > HDL, but after serum is exposed to Cremophor EL in vitro or in vivo substantial binding of Taxol to the lipoprotein dissociation product(s) was observed. The latter could represent an important factor in taxol biodistribution.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bagnarello A. G., Lewis L. A., McHenry M. C., Weinstein A. J., Naito H. K., McCullough A. J., Lederman R. J., Gavan T. L. Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N Engl J Med. 1977 Mar 3;296(9):497–499. doi: 10.1056/NEJM197703032960907. [DOI] [PubMed] [Google Scholar]
- Chervinsky D. S., Brecher M. L., Hoelcle M. J. Cremophor-EL enhances taxol efficacy in a multi-drug resistant C1300 neuroblastoma cell line. Anticancer Res. 1993 Jan-Feb;13(1):93–96. [PubMed] [Google Scholar]
- Friche E., Jensen P. B., Sehested M., Demant E. J., Nissen N. N. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun. 1990;2(9):297–303. [PubMed] [Google Scholar]
- Kongshaug M., Cheng L. S., Moan J., Rimington C. Interaction of cremophor EL with human plasma. Int J Biochem. 1991;23(4):473–478. doi: 10.1016/0020-711x(91)90176-n. [DOI] [PubMed] [Google Scholar]
- Morgan A. R., Garbo G. M., Keck R. W., Selman S. H. New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors. Cancer Res. 1988 Jan 1;48(1):194–198. [PubMed] [Google Scholar]
- Pittman R. C., Green S. R., Attie A. D., Steinberg D. Radiolabeled sucrose covalently linked to protein. A device for quantifying degradation of plasma proteins catabolized by lysosomal mechanisms. J Biol Chem. 1979 Aug 10;254(15):6876–6879. [PubMed] [Google Scholar]
- Schumaker V. N., Puppione D. L. Sequential flotation ultracentrifugation. Methods Enzymol. 1986;128:155–170. doi: 10.1016/0076-6879(86)28066-0. [DOI] [PubMed] [Google Scholar]
- Schuurhuis G. J., Broxterman H. J., Pinedo H. M., van Heijningen T. H., van Kalken C. K., Vermorken J. B., Spoelstra E. C., Lankelma J. The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance. Br J Cancer. 1990 Oct;62(4):591–594. doi: 10.1038/bjc.1990.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slichenmyer W. J., Von Hoff D. D. Taxol: a new and effective anti-cancer drug. Anticancer Drugs. 1991 Dec;2(6):519–530. [PubMed] [Google Scholar]
- Sykes E., Meany M., Schulz V., Kessel D. Separation of plasma lipoproteins with a tabletop ultracentrifuge. Clin Chim Acta. 1992 Jan 31;205(1-2):137–144. doi: 10.1016/s0009-8981(05)80008-7. [DOI] [PubMed] [Google Scholar]
- Warnick G. R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 1986;129:101–123. doi: 10.1016/0076-6879(86)29064-3. [DOI] [PubMed] [Google Scholar]
- Webster L., Linsenmeyer M., Millward M., Morton C., Bishop J., Woodcock D. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Natl Cancer Inst. 1993 Oct 20;85(20):1685–1690. doi: 10.1093/jnci/85.20.1685. [DOI] [PubMed] [Google Scholar]
- Wiernik P. H., Schwartz E. L., Strauman J. J., Dutcher J. P., Lipton R. B., Paietta E. Phase I clinical and pharmacokinetic study of taxol. Cancer Res. 1987 May 1;47(9):2486–2493. [PubMed] [Google Scholar]
- Woodburn K., Kessel D. The alteration of plasma lipoproteins by cremophor EL. J Photochem Photobiol B. 1994 Mar;22(3):197–201. doi: 10.1016/1011-1344(93)06968-9. [DOI] [PubMed] [Google Scholar]
- Woodcock D. M., Jefferson S., Linsenmeyer M. E., Crowther P. J., Chojnowski G. M., Williams B., Bertoncello I. Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res. 1990 Jul 15;50(14):4199–4203. [PubMed] [Google Scholar]